Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 4, 1994 - Issue 11
Submit an article Journal homepage
4
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Patent Update: Cardiovascular & Renal: Endothelin receptor antagonists

Kazumi Shiosaki Neuroscience Research, Abbott Laboratories, Abbott Park, EL, 60064, USA
Pages 1361-1365 | Published online: 03 Mar 2008

References to Primarv Literature

  • YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 332: 411414. Seminal report on the discovery and intitial characterization of endothelin.
  • INOUE A, YANAGISAWA M, KIMURA S, KASUYA Y, MI YAUCHI T, GOTO K, MASAKI T: The human endothelin family: three structurally, pharmacologically distinct isopeptides predicted by three separate genes. Proc. Nat. Acad. Sci . (1989) 86: 2863–2867.
  • SAICURAI T, YANAGISAWA M, MASAKI T: Molecular char- acterization of endothelin receptors. TIPS (1992) 13: 103108.
  • KARNE SJAYAWICICREME CK, LERNER MR: Cloning, char- acterization of an endothelin-3 specific receptor (ETc receptor) from Xertopus laevis dermal melanophores. J. Biol. Chem. (1993) 268: 19126–19133.
  • HAYNES WG, WEBB DJ: The endothelin family of pep-tides: local hormones with diverse roles in health, disease? Clinical Sci. (1993) 84: 485–500.
  • YOKOKAWA K, TAHARA H, KOHNO M, MURAKAWA KYASUNARI, K, NAKAGAWA K, HAMADA T, OTANI S, YANAGISAWA M, TAKEDA T: Hypertension associated with endothelin-secreting malignant hemangioen-dothelioma. Ann. Intern. Med. (1991) 114: 213–215.
  • MIYAUCHI T, YANAGISAWA M, TOMIZAWA T, SUGISHITAY, SUZUKI N, FUJINO M, AJISAKA R, GOTO K, MASAKI T: Increased plasma concentration of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet (1989) 2: 53–54.
  • WATANABE T, SUZUKO N, SHIMAMOTO N, FUJIN° M, IMADA A: Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ. Res. (1991) 69: 370–377.
  • GROVER GJ, DZWONDZYK S, PARHAM CS: The en-dothelin-1 receptor antagonist BQ123 reduces infarct size in a canine model of coronary occlusion, reperfu-sion. Cardiovasc. Res. (1993) 27: 1613–1618.
  • POLLOCK DM, OPGENORTH TJ: Evidence for metallopro-tease involvement in the in vivo effects of big en-dothelia 1. Am.]. Phystot (1991) 261: R257–R263.
  • SIMONSON MS, DUNN MJ: Endothelin peptides, the kid-ney. Annual Rev. Physiol. (1993) 55: 249–265.
  • CHAN L, CHITTINANDANA A, SHAPIRO J, SHANLEY P, SCHRIER R: Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am.J. Physiol (1994) 266: F135-F138. Beneficial effects of BQ-123 in isolated perfused rat kidney.
  • GELLAI M, JUGUS M, FLETCHER T, DEWOLE R, NAMBI P: Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat]. Clin. Invest. (1994) 93: 900–906. BQ-123 significantly increased survival rates in rats subjected to renal artery occlusion.
  • STEWART DJ: Endothelin in cardiopulmonary disease: factor paracrine vs. neurohumoral. Eu. Heart J. (1993) 14: 48–54.
  • HAY DWP, HENRY PJ, GOLDIE RG: Endothelin, the res-piratory system. Trends. Pharmaceut. Sci. (1993) 14: 29–32.
  • BATTISTINI B, CHAILLER P, D'ORLEANSJUSTE P, BRIERE N, SIROIS P: Growth regulatory properties of endothelins. Peptides (1993) 14: 385–399.
  • OHLSTEIN EH, DOUGLAS SA: Endothelin-1 modulates vascular smooth muscle structure, vasomotion: impli-cations in cardiovascular pathology. Drug Development Research (1993) 29: 108–128.
  • DOHERTY AM: Treatments for myocardial ischaemia.Exp. Opin. Tiler. Patents (1994) 4: 531–542.
  • ISHIKAWA K, FUKAMI T, NAGASE T, FujrrA K,HAYAMA T, NIIYAMA K, MASE T, IHARA M, YANO M: Cyclic pentapeptide endothelin antagonists with high ETA-selectivity. Potency and solubility-enhancing modifications. J. Med. Chem. (1992) 33: 2139–2142.
  • SOGABE K, NIREI H, SHOUBO M, NOMOTO A, AO S,NOTSU T, ONO T: Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. Journal of Pharmacological, Experimental Therapeutics (1993) 264: 1040–1046.
  • CODY WE, DOHERTY AM, HE JX, DEPUE PL, RAPUN-DALO ST, HINGORANI GA, MAJOR TC, PANEK RL, DUDLEY DT, HALEEN SJ, LADOUCEUR D, HILL KE, FLYNN MA, REYNOLDS EE: Design of functional hexapeptide antagonist of endothelin. J. Med. Chem. (1992) 35: 3301–3303.
  • ELLIarr JD, LAGO MA, COUSINS RD, GAO A, LEBER JD, ERHARD KF, NAMBI P, ELSHOURBAGY NA, KUMAR C, LEE JA, BEAN jw, DEBROSSE CW, EGGLESTON DS, BROOKS DP, FEUERSTEIN G, RR RUFFOLO J, WEINSTOCK J, GLEA-SON JG, PEISHOFF CE, OHISTEIN E1-1: 1,3-Diarylindan-2-carboxylic acid, potent, selective nonpeptide endothelin receptor antagonists. J. Med. Chem. (1994) 37: 1553–1557
  • ISHIKAWA K, IHARA M, NOGUCHI K, MASE T, MINO N, SAEKI T, FUKURODA T, FUKAMI T, OZAKI 5, NAGASE T, NISHIKIBI M, YANO M: Biochemical and pharmacologi-cal profile of a potent and selective endothelin B-recep-tor antagonist, BQ-788. Proc. Nati . Acad. Sci USA (1994) 91: 4892–4896. References to Patent Literature

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.